Display options
Share it on

Acta Crystallogr Sect E Struct Rep Online. 2014 Mar 26;70:o486-7. doi: 10.1107/S160053681400628X. eCollection 2014 Apr 01.

4-Bromo-2-(5-bromo-thio-phen-2-yl)-1-[(5-bromo-thio-phen-2-yl)meth-yl]-5,6-dimethyl-1H-benzimidazole.

Acta crystallographica. Section E, Structure reports online

H Cristina Geiger, James S Donohoe, David K Geiger

Affiliations

  1. Department of Chemistry, State University of New York-College at Geneseo, 1 College Circle, Geneseo, NY 14454, USA.

PMID: 24826179 PMCID: PMC3998606 DOI: 10.1107/S160053681400628X

Abstract

The title compound, C18H13Br3N2S2, was obtained via the reaction of N-bromo-succinamide with 5,6-dimethyl-2-(thio-phen-2-yl)-1-[(thio-phen-2-yl)meth-yl]-1H-benzimidazole. The compound exhibits rotational disorder of the 5-bromo-thio-phen-2-yl substituent with a refined major:minor occupancy ratio of 0.876 (7):0.124 (7). The 5-bromo-thio-phen-2-yl mean plane is canted to the benzimidazole plane by 20.0 (4) and 21 (4)° in the major and minor components, respectively. In the crystal, weak C-H⋯N inter-actions link the mol-ecules into infinite C(7) chains along the 21 axes.

References

  1. Acta Crystallogr Sect E Struct Rep Online. 2013 Apr 30;69(Pt 5):o807 - PubMed
  2. Chem Rev. 2003 Mar;103(3):893-930 - PubMed
  3. J Med Chem. 1999 Dec 2;42(24):5020-8 - PubMed
  4. Acta Crystallogr D Biol Crystallogr. 2009 Feb;65(Pt 2):148-55 - PubMed
  5. Acta Crystallogr Sect E Struct Rep Online. 2012 Feb 1;68(Pt 2):o420 - PubMed
  6. Acta Crystallogr A. 2008 Jan;64(Pt 1):112-22 - PubMed
  7. Acta Crystallogr Sect E Struct Rep Online. 2012 Nov 1;68(Pt 11):o3123 - PubMed
  8. Acta Crystallogr Sect E Struct Rep Online. 2013 Sep 12;69(Pt 10):o1539-40 - PubMed

Publication Types